J P Briand
Overview
Explore the profile of J P Briand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
1703
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Janko C, Andre S, Munoz L, Briand J, Schorn C, Winkler S, et al.
Lupus
. 2012 May;
21(7):781-3.
PMID: 22635232
Autoantibodies against opsonins of dying and dead cells mediate Fcγ receptor-dependent phagocytosis of autologous apoptotic and necrotic cells and hereby tend to elicit inflammation instead of silent clearance. We analysed...
2.
Hassen E, Briand J, Kacem R, Chaieb A, Khairi H, Zakhama A, et al.
Tunis Med
. 2006 Jan;
83 Suppl 12:61.
PMID: 16430069
No abstract available.
3.
Cohen W, Bianco A, Connan F, Camoin L, Dalod M, Lauvau G, et al.
J Virol
. 2002 Sep;
76(20):10219-25.
PMID: 12239297
Cytotoxic T-lymphocyte (CTL) responses directed to different human immunodeficiency virus (HIV) epitopes vary in their protective efficacy. In particular, HIV-infected cells are much more sensitive to lysis by anti-Gag/p17(77-85)/HLA-A2 than...
4.
Semetey V, Hemmerlin C, Didierjean C, Schaffner A, Giner A, Aubry A, et al.
Org Lett
. 2001 Nov;
3(24):3843-6.
PMID: 11720550
In contrast to the situation observed in the crystal state, the urea moiety in N-Boc-N'-carbamoyl-gem-diaminoalkyl derivatives (single-residue ureidopeptides) 1-4 exclusively assumes a cis-trans conformation in solution. When R(3) = H,...
5.
Krust B, Vienet R, Cardona A, Rougeot C, Jacotot E, Callebaut C, et al.
Proc Natl Acad Sci U S A
. 2001 Nov;
98(24):14090-5.
PMID: 11698640
The HB-19 pseudopeptide 5[Kpsi(CH(2)N)PR]-TASP, psi(CH(2)N) for reduced peptide bond, is a specific inhibitor of HIV infection in different CD4(+) cell lines and in primary T-lymphocytes and macrophages. It blocks virus-particle...
6.
Monneaux F, Dumortier H, Steiner G, Briand J, Muller S
Int Immunol
. 2001 Aug;
13(9):1155-63.
PMID: 11526096
(NZB x NZW)F(1) and MRL/Fas(lpr) lupus mice present a similar phenotype with a spectrum of autoantibodies associated with very severe nephritis. It is thought, however, that in contrast to other...
7.
Furrer J, Piotto M, Bourdonneau M, Limal D, Guichard G, Elbayed K, et al.
J Am Chem Soc
. 2001 Jul;
123(18):4130-8.
PMID: 11457175
The structure of the 19-amino acid peptide epitope, corresponding to the 141-159 sequence of capsid viral protein VP1 of foot-and-mouth disease virus (FMDV), bound to three different resins, namely, polystyrene-MBHA,...
8.
Choppin J, Cohen W, Bianco A, Briand J, Connan F, Dalod M, et al.
J Immunol
. 2001 May;
166(10):6164-9.
PMID: 11342637
First and foremost among the many factors that influence epitope presentation are the degradation of Ag, which results in peptide liberation, and the presence of HLA class I molecules able...
9.
PETIT M, Guichard G, Briand J, Muller S, Cung M
Biochemistry
. 2001 May;
40(19):5720-7.
PMID: 11341837
The three-dimensional structures of the two L-peptides, H-CGGIRGERA-OH, called L(A), and H-CGGIRGERG-OH, called L(G), corresponding or close to the IRGERA sequence present in the C-terminal region (residues 130-135) of histone...
10.
Beignon A, Briand J, Muller S, Partidos C
Immunology
. 2001 Apr;
102(3):344-51.
PMID: 11298834
In this study, the potential of the bare skin as a non-invasive route for vaccination was examined. Following application of heat-labile enterotoxin (LT) of Escherichia coli onto bare skin of...